NINE people have died in an outbreak of an eye-bleeding disease in Tanzania, Africa’s health agency has announced. This ...

Germany’s agriculture minister will seek financial aid for farmers hit by the impact of a case of foot-and-mouth disease on a ...

Last year, they successfully lobbied against the confirmation of Gary Skiba, a hunter, angler, bighorn sheep biologist, and 23-year veteran of Colorado Parks and Wildlife, because he supported wolf ...

What is Cushing's syndrome? Cushing's syndrome is a hormonal disorder. It’s caused when you have high levels of the hormone cortisol over a long time. Cushing's syndrome is fairly rare. It most often ...

AN outbreak of a lethal ‘eye-bleeding’ virus has been confirmed in Tanzania, the president has announced. It comes just a ...

Minister, Andrew Muir, has updated his Stormont Executive colleagues about the ongoing outbreak of Foot and Mouth Disease ...

Fifteen-year-old Dominic Henriquez from Prosper, Texas, is bringing hope to boys like him who live with Hunter syndrome, a rare genetic disorder that primarily affects males. Dominic’s journey ...

The most advanced candidate in the partnership, RGX-121 (clemidsogene lanparvovec), targets Hunter syndrome, also known as MPS II, a condition caused by a mutation in the iduronate-2-sulfatase (IDS) ...

With an FDA approval submission for RegenXBio’s Hunter syndrome gene therapy already underway, the biopharma has now found a commercialization partner for both the U.S. and Asian markets.

The partnership will focus on advancing RGX-121 as a treatment for mucopolysaccharidosis II (MPS II), also known as Hunter syndrome, and RGX-111 for treating mucopolysaccharidosis I (MPS I), also ...

Denali’s wholly owned program, DNL310 or tividenofusp alfa, is an Enzyme Transport Vehicle-enabled iduronate-2-sulfatase (IDS) replacement therapy in development for MPS II (Hunter syndrome).